Systemic Anti-Cancer Therapy Data Set

Systemic Anti-Cancer Therapy Data Set Overview

The Mandatory, Required or Optional (M/R/O) column indicates the recommendation for the inclusion of data.

For guidance on downloading the XML Schema, see XML Schema TRUD Download

For guidance on the XML Schema constraints, see the Systemic Anti-Cancer Therapy Data Set XML Schema Constraints.

DEMOGRAPHICS AND CONSULTANT

To carry personal, organisation and consultant details.
One occurrence of this group is required.
 
M/R/O Data Set Data Elements 
MNHS NUMBER 
MNHS NUMBER STATUS INDICATOR CODE
MPERSON BIRTH DATE 
RPERSON GENDER CODE CURRENT 
RETHNIC CATEGORY 
MPOSTCODE OF USUAL ADDRESS 
RGENERAL MEDICAL PRACTICE CODE (PATIENT REGISTRATION) 
RCONSULTANT CODE (INITIATED SYSTEMIC ANTI-CANCER THERAPY) 
RCARE PROFESSIONAL MAIN SPECIALTY CODE (START SYSTEMIC ANTI-CANCER THERAPY) 
MORGANISATION CODE (CODE OF PROVIDER) 

CLINICAL STATUS

To carry the clinical status details.
One occurrence of this group is required.
 
M/R/O Data Set Data Elements 
MPRIMARY DIAGNOSIS (ICD AT START SYSTEMIC ANTI-CANCER THERAPY)
and/or
MORPHOLOGY (ICD-O AT START SYSTEMIC ANTI-CANCER THERAPY) 
RTNM STAGE GROUPING (FINAL PRETREATMENT)

PROGRAMME AND REGIMEN

To carry details of the Systemic Anti-Cancer Therapy Programme and Systemic Anti-Cancer Drug Regimen.
Multiple occurrences of this group are permitted (at least one must be present).
 
M/R/O Data Set Data Elements 
RSYSTEMIC ANTI-CANCER THERAPY PROGRAMME NUMBER 
RANTI-CANCER REGIMEN NUMBER 
RDRUG TREATMENT INTENT 
MDRUG REGIMEN ACRONYM 
RPERSON HEIGHT IN METRES 
RPERSON WEIGHT 
RPERFORMANCE STATUS (ADULT)
or
PERFORMANCE STATUS (YOUNG PERSON) 
RCO-MORBIDITY ADJUSTMENT INDICATOR 
RDECISION TO TREAT DATE (ANTI-CANCER DRUG REGIMEN) 
MSTART DATE (ANTI-CANCER DRUG REGIMEN) 
RCLINICAL TRIAL INDICATOR 
RCHEMO-RADIATION INDICATOR 
RNUMBER OF SYSTEMIC ANTI-CANCER THERAPY CYCLES PLANNED 

CYCLE

To carry details of each Systemic Anti-Cancer Therapy Cycle.
Multiple occurrences of this group are permitted (at least one must be present).
 
M/R/O Data Set Data Elements 
MANTI-CANCER DRUG CYCLE IDENTIFIER 
RSTART DATE (SYSTEMIC ANTI-CANCER DRUG CYCLE) 
OPERSON WEIGHT 
RPERFORMANCE STATUS (ADULT)
or
PERFORMANCE STATUS (YOUNG PERSON) 
RPRIMARY PROCEDURE (OPCS) 

DRUG DETAILS

To carry details of the Systemic Anti-Cancer Therapy Drugs.
Multiple occurrences of this group are permitted (one occurrence for each Systemic Anti-Cancer Therapy Drug - at least one must be present).
 
M/R/O Data Set Data Elements 
RSYSTEMIC ANTI-CANCER DRUG NAME 
RCHEMOTHERAPY ACTUAL DOSE 
RSYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION 
RSYSTEMIC ANTI-CANCER THERAPY ADMINISTRATION DATE 
RORGANISATION CODE (CODE OF PROVIDER) 
RPRIMARY PROCEDURE (OPCS) 

OUTCOME

To carry details of the outcome / summary.
One occurrence of this group is permitted.
 
M/R/O Data Set Data Elements 
RSTART DATE (FINAL SYSTEMIC ANTI-CANCER THERAPY) 
RSYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (DOSE REDUCTION) 
RSYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (TIME DELAY) 
RSYSTEMIC ANTI-CANCER THERAPY REGIMEN MODIFICATION INDICATOR (DAYS REDUCED) 
RPLANNED TREATMENT CHANGE REASON 
RPERSON DEATH DATE 
ISO 9001 CERTIFICATION EUROPE